From left, Olatomiwa Ajayi, Jarvius Neal, and Keshawn Smith face charges for allegedly kidnapping, torturing, and robbing a neighbor at a luxury condominium building in Downtown Miami.
Liberal heavyweights say the Perth electorate of Curtin is the party’s best chance of reclaiming a seat from the teal independents at the looming federal election, thanks to a surge in ...
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
Feathers and blood stains belonging to the Baikal teal were found on both engines of the crashed Jeju Air plane Investigators say they have found evidence of a bird strike on a passenger plane ...
BENGALURU: Enthused by a burgeoning aerospace market in India and globally, TEAL (Titan Engineering and Automation Limited) is looking at expanding its aerospace components and sub-assemblies ...
Founded in 2019, Teal is now backed by $19 million in investor capital. The startup moved its headquarters from New York City to Miami in early 2021, part of a trend of tech and finance ventures ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.